Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Acquisition/DispositionItem 2.01 · 8-KMEDIUM RiskPositive

Lexeo Therapeutics, Inc.

The company completed buying or selling a business or major assets. An 8-K is the notice a US public company must file within four business days of a major event.

www.lexeotx.com
Filed: Sep 29, 2026New York City, New YorkCIK: 0001907108Health Care
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Lexeo Therapeutics completed its acquisition of Mantle Therapeutics on September 29, 2026, with Mantle becoming a wholly owned subsidiary. This strategic transaction expands Lexeo's therapeutic portfolio and innovation capabilities.

Key Takeaways

Acquisition of Mantle Therapeutics was completed on September 29, 2026, following the Merger Agreement dated September 16, 2026

Mantle Therapeutics is now a wholly owned subsidiary of Lexeo following the merger of Lexeo's subsidiary Magma Merger Sub Inc. with Mantle

2 more takeaways

Filing Overview

Form Type8-K
Filing DateSep 29, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0001907108
Accession #0001193125-26-407555
Risk LevelMEDIUM
SentimentPositive
Signalopportunity
Topics
acquisitionmaterial agreement

What This Means

The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.
View Full Filing on SEC.govBrowse More Filings

Lexeo Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.